share_log

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga ·  Mar 26 01:30

Gainers

  • Landos Biopharma (NASDAQ:LABP) shares rose 173.9% to $21.45 during Monday's regular session. The market value of their outstanding shares is at $66.8 million. The company's, Q4 earnings came out 2 days ago.
  • Altamira Therapeutics (NASDAQ:CYTO) stock moved upwards by 30.63% to $2.26. The market value of their outstanding shares is at $4.1 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) shares increased by 28.24% to $3.36. The company's market cap stands at $18.3 million.
  • Nkarta (NASDAQ:NKTX) shares moved upwards by 23.87% to $11.05. The company's market cap stands at $542.2 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Sagimet Biosciences (NASDAQ:SGMT) stock rose 23.05% to $5.55. The market value of their outstanding shares is at $177.0 million. The company's, FY earnings came out today.
  • Molecular Templates (NASDAQ:MTEM) shares moved upwards by 21.62% to $2.25. The company's market cap stands at $12.0 million.

Losers

  • Trxade Health (NASDAQ:MEDS) stock decreased by 48.6% to $12.38 during Monday's regular session. The company's market cap stands at $14.9 million.
  • SINTX Techs (NASDAQ:SINT) stock declined by 48.01% to $0.05.
  • Akanda (NASDAQ:AKAN) stock decreased by 34.42% to $0.16. The market value of their outstanding shares is at $1.4 million.
  • Invivyd (NASDAQ:IVVD) stock declined by 23.06% to $3.35. The company's market cap stands at $398.7 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock fell 19.88% to $2.22. The market value of their outstanding shares is at $1.6 million.
  • Kineta (NASDAQ:KA) shares decreased by 16.88% to $0.54. The market value of their outstanding shares is at $5.6 million. The company's, Q4 earnings came out 2 days ago.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment